Global liquid biopsy market is projected to witness a steady growth during the forecasted period 2018-2023. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market. however, lack of awareness in developing and underdeveloped countries hamper the growth of the market. Moreover, technological advancement in a liquid biopsy with growing investment and funding for R&D create a future opportunity for the growth of the market during the forecast period.

Request a free sample of our report on Liquid Biopsy Market: https://www.omrglobal.com/request-sample/liquid-biopsy-market

Global liquid biopsy market is segmented on the basis of biomarker type, cancer type, and end-user. According to the biomarker type, the market is further sub-segmented as circulating tumor cells, circulating tumor DNA and others such as extracellular vesicles. According to the cancer type, the market is further diversified as lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. Moreover, according to the end-user, the market is further diversified as hospitals and laboratories, and academic and research institutes.

Global liquid biopsy market can be geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. High prevalence of cancer diseases and the investment in R&D in the US has boosted the growth of the market in North America. The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecasted period. The growth in the Asia-Pacific market is backed by the growing awareness about the diagnosis and treatment for cancer diseases within the countries. Along with it, efforts by the government funding on research programs is aiding in the growth of the Asia-Pacific liquid biopsy market.

A full report of Liquid Biopsy Market is available at: https://www.omrglobal.com/industry-reports/liquid-biopsy-market

Global Liquid Biopsy Market Segmentation

By Biomarker Type

Circulating Tumor Cells

Circulating Tumor DNA (ctDNA)

Others (Extracellular Vesicles)

By Cancer Type

Lung Cancer

Breast Cancer

Prostate Cancer

Colorectal Cancer

Other Cancers

By End-User

Hospitals and Laboratories

Academic and Research Centres

Competitive Landscape

Key Company Analysis

Key Strategy Analysis

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

RoE

Asia-Pacific

India

China

Japan

Rest of Asia-Pacific

Rest of The World

Company Profiles

Biocept Inc.

Biodesix, Inc.

Bio-Rad Laboratories Inc.

CellMax Life

Circulogene

Clearbridge Biomedics Pte Ltd.

Cynvenio Biosystems, Inc.

Epigenomics AG

Exosome Diagnostics Inc.

F. Hoffmann-La Roche AG

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/liquid-biopsy-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404